RBC Bioscience

RBC Bioscience Operating Expenses

The Total Operating Expenses of RBC Bioscience (6848.TWO) as of Nov 6, 2026 is 39.95 M TWD. In the previous year, Total Operating Expenses was 37.07 M TWD — a change of 7.77% (higher).

Operating Expenses

39.95 MTWD

YoY

7.77%

Last updated:

Total Operating Expenses of RBC Bioscience is 2024 39.95 M TWD. Total Operating Expenses of RBC Bioscience was 2023 37.07 M TWD. It decreases by 7.77% higher compared to the previous year.

The RBC Bioscience Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
43.05 M TWD
Jan 1, 2019
23.07 M TWD
Jan 1, 2020
90.28 M TWD
Jan 1, 2021
45.01 M TWD
Jan 1, 2022
42.46 M TWD
Jan 1, 2023
37.07 M TWD
Jan 1, 2024
39.95 M TWD
The RBC Bioscience Operating Expenses history
YEAROperating ExpensesYoY
39.95 MTWD+7.77%
37.07 MTWD-12.69%
42.46 MTWD-5.68%
45.01 MTWD-50.14%
90.28 MTWD+291.39%
23.07 MTWD-46.42%
43.05 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Total Operating Expenses of RBC Bioscience is 39.95 M TWD in 2024.

Total Operating Expenses of RBC Bioscience changed from 37.07 M TWD to 39.95 M TWD, representing a 7.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — RBC Bioscience

All Key Metrics — RBC Bioscience